These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sodium-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Zeitner CJ, Graefe KH. Naunyn Schmiedebergs Arch Pharmacol; 1986 Dec; 334(4):397-402. PubMed ID: 3821932 [Abstract] [Full Text] [Related]
5. Effect of veratridine on the fluxes of 3H-noradrenaline and 3h-bretylium in the rat vas deferens in vitro. Ross SB, Kelder D. Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 295(3):183-9. PubMed ID: 1012341 [Abstract] [Full Text] [Related]
6. The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens. Schömig E, Schönfeld CL, Halbrügge T, Graefe KH, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):160-70. PubMed ID: 2234101 [Abstract] [Full Text] [Related]
8. Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig. Todorov L, Windisch K, Shersen H, Lajtha A, Papasova M, Vizi ES. Br J Pharmacol; 1991 Jan; 102(1):186-90. PubMed ID: 2043921 [Abstract] [Full Text] [Related]
9. Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline. Azevedo I, Moura D, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1990 Aug; 342(2):245-8. PubMed ID: 2234107 [Abstract] [Full Text] [Related]
12. The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium. Schönfeld CL, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):520-6. PubMed ID: 1811169 [Abstract] [Full Text] [Related]
13. Chloride-dependence of the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Ungell AL, Oberleithner H, Graefe KH. Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov; 339(1-2):65-70. PubMed ID: 2725700 [Abstract] [Full Text] [Related]
14. Failure of K+ to affect the potency of inhibitors of the neuronal noradrenaline carrier in the rat vas deferens. Ungell AL, Graefe KH. Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):250-4. PubMed ID: 3587371 [Abstract] [Full Text] [Related]
15. The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline. Langeloh A, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):611-20. PubMed ID: 3444478 [Abstract] [Full Text] [Related]
16. Mechanism of the indirect sympathomimetic effect of 5-hydroxytrypt-amine on the isolated heart of the rabbit. Fozard JR, Mwaluko GM. Br J Pharmacol; 1976 May; 57(1):115-25. PubMed ID: 1276530 [Abstract] [Full Text] [Related]
17. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Kiss JP, Windisch K, Balla A, Sershen H, Lajtha A. Brain Res Bull; 1997 May; 43(3):257-62. PubMed ID: 9227834 [Abstract] [Full Text] [Related]
18. Allosteric interaction of the anticholinergic drug [N-(4-phenyl)-phenacyl-l-hyoscyamine] (Phenthonium) with nicotinic receptors of post-ganglionic sympathetic neurons of the rat vas deferens. Munhoz E, De Lima TC, Souccar C, Lapa AJ, Lima-Landman MT. Eur J Pharmacol; 2009 Aug 15; 616(1-3):229-35. PubMed ID: 19540221 [Abstract] [Full Text] [Related]
19. The extent of neuronal re-uptake of 3H-noradrenaline in isolated vasa deferentia and atria of the rat. Schömig E, Fischer P, Schönfeld CL, Trendelenburg U. Naunyn Schmiedebergs Arch Pharmacol; 1989 Nov 15; 340(5):502-8. PubMed ID: 2559332 [Abstract] [Full Text] [Related]
20. Conclusive evidence for distinct transporters for 5-hydroxytryptamine and noradrenaline in pulmonary endothelial cells of the rat. Paczkowski NJ, Vuocolo HE, Bryan-Lluka LJ. Naunyn Schmiedebergs Arch Pharmacol; 1996 Mar 15; 353(4):423-30. PubMed ID: 8935709 [Abstract] [Full Text] [Related] Page: [Next] [New Search]